ESC 365 - T309I-Kv7.1 mutation as a feasible founder LQT1 mutation: clinical, genetic and biophysical analysis

EHRA Premium Access

T309I-Kv7.1 mutation as a feasible founder LQT1 mutation: clinical, genetic and biophysical analysis

Session: Translation of cardiac cellular electrophysiology

Topic: Mechanism (Basic Science in Arrhythmias)

Speaker: Associate Professor M. Bebarova (Brno, CZ)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Marketa Bebarova

Masaryk University, Brno (Czechia)

0 follower

3 more presentations in this session

SK channels as putative antiarrhythmic targets.

Speaker: Professor T. Jespersen (Copenhagen, DK)

Chronic endurance exercise induces ion channel remodelling and dysfunction of the atrioventricular node

Speaker: Doctor A. D'souza (London, GB)

Hamamy syndrome: Deciphering the role of IRX5 transcription factor in the regulation of human cardiac electrical conduction

Speaker: Miss Z. Reda Al Sayed (Nantes, FR)

Access the full session

Translation of cardiac cellular electrophysiology

Speakers: Associate Professor M. Bebarova, Professor T. Jespersen, Doctor A. D'souza, Miss Z. Reda Al Sayed

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources